Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

Share Price is delayed by 15 minutes
Get Live Data
499.40    0.00 (0.00%)
Bid:
0.00
Ask:
600.00
Spread: 100.00 (20.00%)
Market Cap: £1.35b
CHG Live PriceLast checked at - London Stock Exchange

Intraday Chemring Share Chart

POST-CLOSE STATEMENT

14 Nov 2017 07:00

RNS Number : 3823W
Chemring Group PLC
14 November 2017
 

FOR IMMEDIATE RELEASE 14 NOVEMBER 2017

 

CHEMRING GROUP PLC

 

POST-CLOSE STATEMENT

 

Chemring Group PLC ("Chemring" or "the Group") today provides its post-close statement in respect of the year ended 31 October 2017.

 

FY17 trading

 

The Group's trading performance for the year to 31 October 2017 ("FY17") is expected to be slightly ahead of the Board's expectations.

 

Strong delivery performance in the final quarter of FY17 has led to full year revenue of £547m, an increase of 15% on the prior year (2016: £477m).

 

The Group's order book at 31 October 2017 was £478m (2016: £593m). The decline in the order book principally reflects the conclusion of the 40mm ammunition contract to a customer in the Middle East, awarded in 2016, as well as a currency headwind of £33m experienced this year. A number of significant orders were received by both our US and UK Countermeasures businesses in the second half of the year, giving increased confidence in the Group's prospects in the near term.

 

Financial position

 

At 31 October 2017, net debt was £80.0m (2016: £87.6m).

 

Of the Group's £114.3m outstanding US private placement loan notes, £51.3m was repaid yesterday, 13 November 2017, from existing bank debt facilities and cash resources. The remaining loan notes are scheduled to be repaid in November 2019 (£63.0m).

 

The Group's FY17 results are scheduled to be announced on 18 January 2018.

 

-ENDS-

 

For further information:

 

Rupert Pittman Group Director of Corporate Affairs, 01794 833901

Chemring Group PLC

 

Andrew Jaques MHP Communications 020 3128 8100

James White

 

Notes to editors

· Chemring is a global business that specialises in the manufacture of high technology products and the provision of services to the aerospace, defence and security markets

· Employing approximately 2,500 people worldwide, and with production facilities in four countries, Chemring meets the needs of customers in more than fifty countries

· Chemring is organised under three strategic product segments: Countermeasures, Sensors, and Energetics

· Chemring has a diverse portfolio of products that deliver high reliability solutions to protect people, platforms, missions and information against constantly changing threats

· Operating in niche markets and with strong investment in research and development ("R&D"), Chemring has the agility to rapidly react to urgent customer needs

 

www.chemring.co.uk

 

Cautionary statements

This announcement contains unaudited information based on management accounts and forward-looking statements that are based on current expectations or beliefs, as well as assumptions about future events. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as anticipate, target, expect, estimate, intend, plan, goal, believe, will, may, should, would, could, is confident, or other words of similar meaning. Undue reliance should not be placed on any such statements because they speak only as at the date of this document and, by their very nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results, and Chemring's plans and objectives, to differ materially from those expressed or implied in the forward-looking statements.

 

There are a number of factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among the factors that could cause actual results to differ materially from those described in the forward-looking statements are; increased competition, the loss of or damage to one or more key customer relationships, changes to customer ordering patterns, delays in obtaining customer approvals for engineering or price level changes, the failure of one or more key suppliers, the outcome of business or industry restructuring, the outcome of any litigation, changes in economic conditions, currency fluctuations, changes in interest and tax rates, changes in raw material or energy market prices, changes in laws, regulations or regulatory policies, developments in legal or public policy doctrines, technological developments, the failure to retain key management, or the key timing and success of future acquisition opportunities or major investment projects.

 

Chemring undertakes no obligation to revise or update any forward-looking statement contained within this announcement, regardless of whether those statements are affected as a result of new information, future events or otherwise, save as required by law and regulations.

 

No statement in this announcement is intended as a profit forecast for FY17 and no statement in this announcement should be interpreted to mean that underlying operating profit for the current or future financial years would necessarily be above a minimum level, or match or exceed the historical published underlying operating profit or set a minimum level of underlying operating profit.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGGBUGUPMPPW
Date   Source Headline
25th Mar 202012:57 pmRNSDirector/PDMR Shareholding
24th Mar 20202:18 pmRNSHolding(s) in Company
5th Mar 20204:01 pmRNSDoc re. Ordinary & Special Resolutions
4th Mar 20202:55 pmRNSResult of AGM
4th Mar 20207:00 amRNSAGM Trading Update
2nd Mar 202011:13 amRNSTotal Voting Rights
28th Feb 20201:32 pmRNSHolding(s) in Company
3rd Feb 202010:09 amRNSTotal Voting Rights
29th Jan 202012:16 pmRNSAdditional Listing
23rd Jan 20205:18 pmRNSDirector/PDMR Shareholding
21st Jan 202010:08 amRNSNotice of AGM
20th Jan 20204:40 pmRNSDirector/PDMR Shareholding
2nd Jan 20205:32 pmRNSTotal Voting Rights
23rd Dec 201910:50 amRNSHolding(s) in Company
18th Dec 201910:36 amRNSBlock listing Interim Review
17th Dec 20194:12 pmRNSHolding(s) in Company
17th Dec 20191:13 pmRNSDirector/PDMR Shareholding
17th Dec 20191:11 pmRNSDirector/PDMR Shareholding
17th Dec 20191:10 pmRNSDirector/PDMR Shareholding
17th Dec 20191:07 pmRNSDirector/PDMR Shareholding
17th Dec 20191:05 pmRNSDirector/PDMR Shareholding
17th Dec 20191:02 pmRNSDirector/PDMR Shareholding
16th Dec 20197:01 amRNSDirectorate changes
16th Dec 20197:00 amRNSResults for the year ended 31 October 2019
11th Dec 201910:20 amRNSHolding(s) in Company
2nd Dec 201912:13 pmRNSTotal Voting Rights
26th Nov 20191:23 pmRNSHolding(s) in Company
21st Nov 20197:00 amRNSDisposal of Chemring Ordnance
6th Nov 20192:34 pmRNSHolding(s) in Company
1st Nov 201910:57 amRNSTotal Voting Rights
1st Nov 20197:00 amRNSContract award and year-end update
14th Oct 20194:32 pmRNSDirector/PDMR Shareholding
1st Oct 201912:09 pmRNSTotal Voting Rights
13th Sep 201912:55 pmRNSHolding(s) in Company
13th Sep 201912:52 pmRNSHolding(s) in Company
12th Sep 20192:29 pmRNSHolding(s) in Company
11th Sep 20197:00 amRNSContract Awards
11th Sep 20197:00 amRNSTrading Update
4th Sep 20192:41 pmRNSHolding(s) in Company
2nd Sep 201912:29 pmRNSTotal Voting Rights
1st Aug 201911:04 amRNSTotal Voting Rights
30th Jul 20197:00 amRNSDirectorate Change
4th Jul 20194:22 pmRNSHolding(s) in Company
1st Jul 201910:31 amRNSTotal Voting Rights
24th Jun 201910:09 amRNSBlock listing Update
24th Jun 20199:52 amRNSBlock listing Interim Review
24th Jun 20197:00 amRNSDisposal of Chemring Defence
5th Jun 20197:00 amRNSInterim results
3rd Jun 20199:52 amRNSTotal Voting Rights
10th May 20197:00 amRNSPost Close Statement and Contract Win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.